HOLON, Israel (AP) _ Compugen Ltd. (CGEN) on Friday reported a loss of $6.2 million in its third quarter.

The Holon, Israel-based company said it had a loss of 7 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.

The drug developer posted revenue of $6 million in the period.

Compugen shares have fallen 41% since the beginning of the year. The stock has declined 45% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGEN at https://www.zacks.com/ap/CGEN

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News